The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Describe clinical contexts in which molecular testing may be useful for management of cutaneous melanoma.
Explain the challenges to using and interpreting molecular testing for diagnostic or prognostic purposes.
Review molecular testing options for patients with stage III or stage IV disease, what material should be used for testing, and how results may inform treatment decisions.